4.6 Review

β-Glucan Metabolic and Immunomodulatory Properties and Potential for Clinical Application

Journal

JOURNAL OF FUNGI
Volume 6, Issue 4, Pages -

Publisher

MDPI
DOI: 10.3390/jof6040356

Keywords

β -glucan; clinical trials; biomedicine; immunomodulation; metabolism

Ask authors/readers for more resources

beta-glucans are complex polysaccharides that are found in several plants and foods, including mushrooms. beta-glucans display an array of potentially therapeutic properties. beta-glucans have metabolic and gastro-intestinal effects, modulating the gut microbiome, altering lipid and glucose metabolism, reducing cholesterol, leading to their investigation as potential therapies for metabolic syndrome, obesity and diet regulation, gastrointestinal conditions such as irritable bowel, and to reduce cardiovascular and diabetes risk. beta-glucans also have immune-modulating effects, leading to their investigation as adjuvant agents for cancers (solid and haematological malignancies), for immune-mediated conditions (e.g., allergic rhinitis, respiratory infections), and to enhance wound healing. The therapeutic potential of beta-glucans is evidenced by the fact that two glucan isolates were licensed as drugs in Japan as immune-adjuvant therapy for cancer in 1980. Significant challenges exist to further clinical testing and translation of beta-glucans. The diverse range of conditions for which beta-glucans are in clinical testing underlines the incomplete understanding of the diverse mechanisms of action of beta-glucans, a key knowledge gap. Furthermore, important differences appear to exist in the effects of apparently similar beta-glucan preparations, which may be due to differences in sources and extraction procedures, another poorly understood issue. This review will describe the biology, potential mechanisms of action and key therapeutic targets being investigated in clinical trials of beta-glucans and identify and discuss the key challenges to successful translation of this intriguing potential therapeutic.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Biochemistry & Molecular Biology

Pathogenic Drug Resistant Fungi: A Review of Mitigation Strategies

Mary Garvey, Neil J. Rowan

Summary: Fungal pathogens pose a significant threat to human health, especially among vulnerable individuals. The emergence of antifungal drug resistance has further complicated the treatment of cutaneous, invasive, and bloodstream infections. To tackle this crisis, the World Health Organization has prioritized fungal pathogens, emphasizing the urgent need for solutions. This review discusses the challenges of antifungal drug resistance, highlights the effectiveness of current disease mitigation approaches, and calls for a better understanding of fungal resistance mechanisms.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Pharmacology & Pharmacy

Hybrid Manufacturing of Oral Solid Dosage Forms via Overprinting of Injection-Molded Tablet Substrates

Han Xu, Farnoosh Ebrahimi, Ke Gong, Zhi Cao, Evert Fuenmayor, Ian Major

Summary: This study explored the use of fused filament fabrication and injection molding to create patient-specific solid dosage forms. Theophylline was combined with polycaprolactone and Kollidon((R)) VA64 via hot-melt extrusion to produce the filament. Results showed that theophylline had a flow promoting effect on the polymer blend and that overprinted tablets were manufactured faster than 3D-printed tablets. Drug release studies also showed that overprinted tablets released faster than injection-molded tablets. This method demonstrates the potential of hybrid manufacturing for the pharmaceutical industry to bridge the gap between personalized dosage forms and mass production.

PHARMACEUTICS (2023)

Article Environmental Sciences

Current decontamination challenges and potentially complementary solutions to safeguard the vulnerable seafood industry from recalcitrant human norovirus in live shellfish: Quo Vadis?

Neil J. Rowan

Summary: Safeguarding the seafood industry is crucial to protect human health. However, eliminating enteric viruses, especially in live shellfish, is challenging. Current disinfection methods are effective against bacteria but have limited effectiveness against enteric viruses. Therefore, alternative non-thermal technologies and novel diagnostic approaches are needed to ensure the safety of shellfish. Risk management planning and real-time ecosystem monitoring are also important for mitigating potential contaminant threats.

SCIENCE OF THE TOTAL ENVIRONMENT (2023)

Review Environmental Sciences

Challenges and future opportunities to unlock the critical supply chain of personal and protective equipment (PPE) encompassing decontamination and reuse under emergency use authorization (EUA) conditions during the COVID-19 pandemic: Through a reflective circularity and sustainability lens

Neil J. Rowan

Summary: The COVID-19 pandemic was declared a global public health emergency by the WHO. There was a lack of knowledge on how to respond to the pandemic and manage the disease. Methods for safe reuse of personal protective equipment have been developed, and these methods can also be applied to decontaminate large volumes of waste. Effective disease mitigation strategies are needed to address the challenges posed by COVID-19 variants.

SCIENCE OF THE TOTAL ENVIRONMENT (2023)

Article Environmental Sciences

Seafood consumers engagement in reducing environmental impacts from packaging

Cheila Almeida, Jara Laso, David Baptista de Sousa, Ronan Cooney, Paula Quinteiro, Neil Rowan, Ana Claudia Dias, Eoghan Clifford, Rodrigo G. Reboredo, Maria Margallo, Maria Leonor Nunes, Antonio Marques

Summary: Packaging is crucial for food protection, consumer information, and waste reduction, but it can also negatively impact the environment. Recycling waste treatment offers more environmental benefits, yet only 66% of packaging waste is recycled in the EU. To minimize environmental impact, reducing packaging production and promoting reuse are the key approaches. Assessing consumer willingness to reduce environmental impact of seafood packaging is important.

SCIENCE OF THE TOTAL ENVIRONMENT (2023)

Article Cell & Tissue Engineering

Nebulised mesenchymal stem cell derived extracellular vesicles ameliorate E. coli induced pneumonia in a rodent model

Hector Gonzalez, Sean McCarthy, Claire Masterson, Declan Byrnes, Ignacio Sallent, Emma Horan, Stephen J. Elliman, Gabriele Vella, Adriele P. Mello, Johnatas D. Silva, Anna D. Krasnodembskaya, Ronan MacLoughlin, John G. Laffey, Daniel O'Toole

Summary: In this study, the therapeutic potential of directly nebulised MSC-EVs in mitigating Escherichiacoli-induced pneumonia was investigated. The results showed that MSC-EVs retained their immunomodulatory and wound healing capacity after nebulisation. Treatment with IV or nebulised MSC-EVs reduced the severity of LPS-induced lung injury and E. coli-induced pneumonia.

STEM CELL RESEARCH & THERAPY (2023)

Review Polymer Science

Polysaccharides-Naturally Occurring Immune Modulators

Emma J. Murphy, Gustavo Waltzer Fehrenbach, Ismin Zainol Abidin, Ciara Buckley, Therese Montgomery, Robert Pogue, Patrick Murray, Ian Major, Emanuele Rezoagli

Summary: The prevention and treatment of diseases require effective functioning immune systems, which can be achieved by eliminating infections and abnormal cells. Immune or biological therapy can stimulate or inhibit the immune system depending on the circumstances. Polysaccharides, abundant biomacromolecules in plants, animals, and microbes, interact with and affect the immune response, playing a crucial role in treating various human illnesses. There is an urgent need to identify natural biomolecules that can prevent infection and treat chronic diseases. This article discusses the therapeutic potential of naturally occurring polysaccharides, extraction methods, and immunological modulatory capabilities.

POLYMERS (2023)

Letter Critical Care Medicine

WEAN SAFE and the definition of the first separation attempt

Tai Pham, Leo Heunks, Giacomo Bellani, Laurent Brochard, John Laffey

LANCET RESPIRATORY MEDICINE (2023)

Article Critical Care Medicine

Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, aTREM-1 inhibitor, in patients with septic shock (ASTONISH) : a double-blind, randomised, controlled, phase 2b trial

Bruno Francois, Simon Lambden, Tom Fivez, Sebastien Gibot, Marc Derive, Jean-Marie Grouin, Margarita Salcedo-Magguilli, Jeremie Lemarie, Nicolas De Schryver, Ville Jalkanen, Tarik Hicheur, Jean-Jacques Garaud, Valerie Cuvier, Ricard Ferrer, Morten Bestle, Ville Pettila, Jean-Paul Mira, Camille Bouisse, Emmanuelle Mercier, Joris Vermassen, Vincent Huberlant, Isabelle Vinatier, Nadia Anguel, Mitchell Levy, Pierre-Francois Laterre

Summary: This study aimed to investigate whether the TREM-1 inhibitor nangibotide could improve outcomes in patients with septic shock. The findings suggest that both low and high doses of nangibotide did not significantly improve the condition of patients with septic shock compared to placebo.

LANCET RESPIRATORY MEDICINE (2023)

Article Anesthesiology

Development and assessment of the performance of a shared ventilatory system that uses clinically available components to individualize tidal volumes

David M. Hannon, Tim Jones, Jack Conolly, Conor Judge, Talha Iqbal, Atif Shahzad, Michael Madden, Frank Kirrane, Peter Conneely, Brian H. Harte, Martin O'Halloran, John G. Laffey

Summary: Developed and assessed a system for shared ventilation using clinically available components to individualize tidal volumes. The system allowed accurate and reproducible titration of tidal volumes to each limb over a range of ventilator settings and simulated lung conditions.

BMC ANESTHESIOLOGY (2023)

Article Polymer Science

Designing Sustainable Polymer Blends: Tailoring Mechanical Properties and Degradation Behaviour in PHB/PLA/PCL Blends in a Seawater Environment

Leonardo G. Engler, Naiara C. Farias, Janaina S. Crespo, Noel M. Gately, Ian Major, Romina Pezzoli, Declan M. Devine

Summary: This study aimed to modify the mechanical and degradation properties of biodegradable polymers by blending different polymers. It was found that poly(lactic acid) (PLA) exhibited the highest tensile strength (67 MPa), while the addition of poly(hydroxybutyrate) (PHB) and polycaprolactone (PCL) increased the flexibility of the samples. Moreover, the degradation of the blends in seawater occurred through bulk and surface erosion mechanisms.

POLYMERS (2023)

Article Biochemistry & Molecular Biology

Synergy Assessment of Four Antimicrobial Bioactive Compounds for the Combinational Treatment of Bacterial Pathogens

Kevin Masterson, Ian Major, Mark Lynch, Neil Rowan

Summary: Antimicrobial resistance (AMR) is a growing concern, and this study evaluates the potential synergistic effects of four antimicrobial bioactives, namely silver nitrate, nisin, chitosan, and zinc oxide, as alternative treatments for AMR bacteria. The combinations of these bioactives were tested against E. coli, S. aureus, and S. epidermidis, and interesting interactions were observed. Silver nitrate significantly enhanced the efficacy of its paired treatment, and nisin showed antimicrobial effects when combined with silver nitrate or chitosan. This study presents innovative methods and results that can be utilized for future research in identifying alternative treatments for AMR.

BIOMEDICINES (2023)

Article Critical Care Medicine

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

Marius Troseid, Jose R. Arribas, Lambert Assoumou, Aleksander Rygh Holten, Julien Poissy, Vida Terzic, Fulvia Mazzaferri, Jesus Rodriguez Bano, Joe Eustace, Maya Hites, Michael Joannidis, Jose-Artur Paiva, Jean Reuter, Isabel Puentmann, Thale D. J. H. Patrick-Brown, Elin Westerheim, Katerina Nezvalova-Henriksen, Lydie Beniguel, Tuva Borresdatter Dahl, Maude Bouscambert, Monika Halanova, Zoltan Peterfi, Sotirios Tsiodras, Michael Rezek, Matthias Briel, Serhat Unal, Martin Schlegel, Florence Ader, Karine Lacombe, Cecilie Delphin Amdal, Serge Rodrigues, Kristian Tonby, Alexandre Gaudet, Lars Heggelund, Joy Mootien, Asgeir Johannessen, Jannicke Horjen Moller, Beatriz Diaz Pollan, Anders Aune Tveita, Anders Benjamin Kildal, Jean-Christophe Richard, Olav Dalgard, Victoria Charlotte Simensen, Aliou Balde, Lucie de Gastines, Marta del Alamo, Burc Aydin, Fridtjof Lund-Johansen, Mary-Anne Trabaud, Alpha Diallo, Bente Halvorsen, John-Arne Rottingen, Evelina Tacconelli, Yazdan Yazdanpanah, Inge C. Olsen, Dominique Costagliola

Summary: The study conducted a placebo-controlled trial of baricitinib in severe/critical COVID cases. The results showed that baricitinib did not reduce mortality within 60 days, and there may be safety risks in vaccinated participants, which require further investigation.

CRITICAL CARE (2023)

Meeting Abstract Critical Care Medicine

PRONE POSITIONING FOR NONINTUBATED COVID-19 PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Jie Li, Jian Luo, Ivan Pavlov, Yonatan Perez, Aileen Kharat, Elsa Tavernier, David Vines, Oriol Roca, Bairbre McNicholas, Miguel Ibarra-Estrada, John Laffey, Claude Guerin, Stephan Ehrmann

CRITICAL CARE MEDICINE (2023)

Article Critical Care Medicine

Epidemiology and outcomes of early-onset AKI in COVID-19-related ARDS in comparison with non-COVID-19-related ARDS: insights from two prospective global cohort studies

Bairbre A. A. McNicholas, Emanuele Rezoagli, Andrew J. J. Simpkin, Sankalp Khanna, Jacky Y. Y. Suen, Pauline Yeung, Daniel Brodie, Gianluigi Li Bassi, Tai Pham, Giacomo Bellani, John F. F. Fraser, John Laffey

Summary: AKI is a common and serious complication in COVID-19 patients, with different characteristics and outcomes compared to non-COVID-19 ARDS patients.

CRITICAL CARE (2023)

No Data Available